Literature DB >> 189279

Radiologic recognition of adriamycin cardiotoxicity.

R M Heller, K Sang Oh, H Kaizer, A Musikabhumma.   

Abstract

A case of congestive heart failure in a child with Wilms' tumor treated Adriamycin is presented and discussed. The role of Adriamycin in the production of cardiotoxicity is reviewed.

Entities:  

Mesh：

Substances：

Year:  1976        PMID： 189279     DOI： 10.1007/bf00988662

Source DB:  PubMed          Journal:  Pediatr Radiol        ISSN： 0301-0449


  7 in total

1.  Adriamycin cardiotoxicity in a child with Wilms tumor. Report of a case and review of the literature.

Authors:  M A Gerber; E M Gilbert; K J Chung
Journal:  J Pediatr       Date:  1975-10       Impact factor: 4.406

Review 2.  Adriamycin. A new anticancer drug with significant clinical activity.

Authors:  R H Blum; S K Carter
Journal:  Ann Intern Med       Date:  1974-02       Impact factor: 25.391

3.  Adriamycin--an antitumor antibiotic in the treatment of neoplastic diseases.

Authors:  C Tan; E Etcubanas; N Wollner; G Rosen; A Gilladoga; J Showel; M L Murphy; I H Krakoff
Journal:  Cancer       Date:  1973-07       Impact factor: 6.860

4.  A clinicopathologic analysis of adriamycin cardiotoxicity.

Authors:  E A Lefrak; J Pitha; S Rosenheim; J A Gottlieb
Journal:  Cancer       Date:  1973-08       Impact factor: 6.860

5.  Phase II evaluation of adriamycin in human neoplasia.

Authors:  R M O'Bryan; J K Luce; R W Talley; J A Gottlieb; L H Baker; G Bonadonna
Journal:  Cancer       Date:  1973-07       Impact factor: 6.860

6.  Clinical trials with adriamycin.

Authors:  E Middleman; J Luce; E Frei
Journal:  Cancer       Date:  1971-10       Impact factor: 6.860

7.  Adriamycin (14-hydroxydaunomycin), a novel antitumor antibiotic.

Authors:  F Arcamone; G Franceschi; S Penco; A Selva
Journal:  Tetrahedron Lett       Date:  1969-03       Impact factor: 2.415
  7 in total
  1 in total

1.  Assessment of adriamycin cardiotoxicity in children by systolic time intervals.

Authors:  H E Ulmer; R Ludwig; H Geiger
Journal:  Eur J Pediatr       Date:  1979-04-25       Impact factor: 3.183
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.